Due to the limited support from previous studies regarding the role of serum APOA1 in NAFLD, in this study, we employed large-scale clinical data to test the association between the variation of APOA1 levels and the prevalence of NAFLD. The gene discussed is APOA1; the disease is metabolic dysfunction-associated steatotic liver disease.